ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 236 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $24,390,000 | -12.2% | 1,000,000 | -7.1% | 0.48% | -20.5% |
| Q1 2021 | $27,766,000 | -67.8% | 1,076,200 | -33.3% | 0.61% | -66.8% |
| Q4 2020 | $86,204,000 | +32.8% | 1,612,500 | +2.5% | 1.83% | +11.0% |
| Q3 2020 | $64,895,000 | +26.9% | 1,573,200 | +49.1% | 1.65% | +17.4% |
| Q2 2020 | $51,136,000 | +18.1% | 1,055,000 | +2.9% | 1.40% | -21.7% |
| Q1 2020 | $43,306,000 | +51.1% | 1,025,000 | +53.0% | 1.79% | +97.7% |
| Q4 2019 | $28,663,000 | +325.9% | 670,000 | +258.3% | 0.91% | +238.1% |
| Q3 2019 | $6,730,000 | -1.8% | 187,000 | +2.7% | 0.27% | -15.2% |
| Q3 2017 | $6,856,000 | +41.3% | 182,000 | +4.6% | 0.32% | +29.0% |
| Q2 2017 | $4,853,000 | +518.2% | 174,000 | +453.8% | 0.24% | -12.5% |
| Q4 2013 | $785,000 | – | 31,418 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |